Pharmacological intervention of the TGFβ signaling was sufficient to inhibit the proliferation and promote the differentiation of the Ahr-/- cancer-propagating cells of the SHH medulloblastomas 28. The gene discussed is TGFB1; the disease is medulloblastoma.